Labeler
Amneal Pharmaceuticals NY LLC NDC Codes
Amneal Pharmaceuticals NY LLC lists 331 finished drug products in the FDA NDC Directory under NDC labeler codes 60219, 69238.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Eltrombopag Olamine, Isotretinoin, Lenalidomide, Estradiol, Amlodipine Besylate and Benazepril Hydrochloride, Deflazacort, Carvedilol Phosphate, Tacrolimus, prednisolone acetate, Sacubitril and Valsartan, Loteprednol Etabonate, Everolimus, Ciprofloxacin, Mirabegron, Sertraline HCl
- Active ingredients
- Eltrombopag olamine, Isotretinoin, Lenalidomide, Estradiol, Amlodipine besylate, Benazepril hydrochloride, Deflazacort, Carvedilol phosphate, Tacrolimus, Prednisolone acetate, Sacubitril, Valsartan
- NDC labeler codes
- 60219, 69238
- Strengths (from the 100 most recently listed products)
- Prednisolone acetate 10 mg/mL; Benazepril hydrochloride 10 mg/1; Amlodipine besylate 5 mg/1; Benazepril hydrochloride 20 mg/1; Eltrombopag olamine 75 mg/1; Eltrombopag olamine 50 mg/1; Eltrombopag olamine 25 mg/1; Eltrombopag olamine 12.5 mg/1; Neomycin sulfate 3.5 mg/mL; Polymyxin b sulfate 10000 [USP'U]/mL; Hydrocortisone 10 mg/mL; Pilocarpine hydrochloride 12.5 mg/mL; Loteprednol etabonate 2 mg/mL; Macitentan 10 mg/1; Tretinoin .8 mg/g; Etoposide 50 mg/1; Mirabegron 25 mg/1; Mirabegron 50 mg/1; Amlodipine besylate 2.5 mg/1; Amlodipine besylate 10 mg/1
- Dosage forms
- Capsule, Tablet, Film coated, Gel, Capsule, Extended release, Suspension/ drops, Tablet, Solution/ drops, Tablet, For suspension, Spray, Metered, Powder, For suspension, Suspension, Tablet, Film coated, Extended release, Aerosol, Metered, Cream, Kit, Inhalant, Patch, Extended release, Injection, Suspension, Suppository, Tablet, Delayed release, Spray, Granule, For solution, For solution, Solution
- Routes
- Oral, Ophthalmic, Topical, Nasal, Respiratory (Inhalation), Auricular (Otic), Transdermal, Intramuscular, Rectal
- Drug classes (FDA established)
- Corticosteroid, Thrombopoietin Receptor Agonist, Retinoid, Dihydropyridine Calcium Channel Blocker, Thalidomide Analog, Estrogen, Angiotensin Converting Enzyme Inhibitor, Calcium Channel Blocker, alpha-Adrenergic Blocker, beta-Adrenergic Blocker, Calcineurin Inhibitor Immunosuppressant, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, Kinase Inhibitor, mTOR Inhibitor Immunosuppressant, Fluoroquinolone Antibacterial, beta3-Adrenergic Agonist, Serotonin Reuptake Inhibitor, Aminoglycoside Antibacterial, Polymyxin-class Antibacterial, Cholinergic Receptor Agonist, Serotonin-4 Receptor Agonist, Nonsteroidal Anti-inflammatory Drug, Serotonin-1b and Serotonin-1d Receptor Agonist, Protease Inhibitor, Macrolide Antimicrobial, Macrolide, Endothelin Receptor Antagonist, Topoisomerase Inhibitor, beta2-Adrenergic Agonist, Prostaglandin Analog, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Anticholinergic, Progestin, Reducing and Complexing Thiol, Ergot Derivative, Histamine-1 Receptor Antagonist, Histamine-2 Receptor Antagonist, Opioid Antagonist, Antimetabolite Immunosuppressant, Aluminum Complex, Phosphodiesterase 5 Inhibitor, Anti-epileptic Agent, Aldosterone Antagonist, Tricyclic Antidepressant, Glycopeptide Antibacterial, Sulfone
- HCPCS / J-code
- J1050 — Injection, medroxyprogesterone acetate, 1 mg
- Package NDCs
- 136 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | 69238-2733 | 69238-2733-0169238-2733-02 | — |
| Loteprednol Etabonate | Loteprednol etabonate 5 mg/mL | Suspension/ dropsOphthalmic | 60219-1362 | 60219-1362-0160219-1362-0260219-1362-03 | — |
| Pilocarpine Hydrochloride Ophthalmicpilocarpine hydrochloride | Pilocarpine hydrochloride 12.5 mg/mL | Solution/ dropsOphthalmic | 60219-2366 | 60219-2366-02 | — |
| Indomethacin | Indomethacin 50 mg/1 | SuppositoryRectal | 69238-2086 | 69238-2086-03 | — |
| Lenalidomide | Lenalidomide 2.5 mg/1 | CapsuleOral | 60219-1714 | 60219-1714-0160219-1714-02 | — |
| Lenalidomide | Lenalidomide 5 mg/1 | CapsuleOral | 60219-1715 | 60219-1715-0160219-1715-02 | — |
| Lenalidomide | Lenalidomide 10 mg/1 | CapsuleOral | 60219-1716 | 60219-1716-0160219-1716-02 | — |
| Lenalidomide | Lenalidomide 15 mg/1 | CapsuleOral | 60219-1717 | 60219-1717-0160219-1717-02 | — |
| Lenalidomide | Lenalidomide 20 mg/1 | CapsuleOral | 60219-1718 | 60219-1718-0160219-1718-02 | — |
| Lenalidomide | Lenalidomide 25 mg/1 | CapsuleOral | 60219-1719 | 60219-1719-0160219-1719-02 | — |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | 60219-2279 | 60219-2279-02 | — |
| Everolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | 60219-2280 | 60219-2280-02 | — |
| Everolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | 60219-2281 | 60219-2281-02 | — |
| tiopronin | Tiopronin 300 mg/1 | Tablet, Delayed releaseOral | 60219-2009 | 60219-2009-09 | — |
| loteprednol etabonate | Loteprednol etabonate 2 mg/mL | Suspension/ dropsOphthalmic | 60219-1366 | 60219-1366-03 | — |
| loteprednol etabonate | Loteprednol etabonate 2 mg/mL | Suspension/ dropsOphthalmic | 60219-1367 | 60219-1367-06 | — |
| Nicardipine hydrochloridenicardipine | Nicardipine hydrochloride 20 mg/1 | CapsuleOral | 69238-2691 | 69238-2691-01 | — |
| Nicardipine hydrochloridenicardipine | Nicardipine hydrochloride 30 mg/1 | CapsuleOral | 69238-2692 | 69238-2692-01 | — |
| Cabergoline | Cabergoline .5 mg/1 | TabletOral | 69238-2693 | 69238-2693-01 | — |
| Bromfenac | Bromfenac sodium .7 mg/mL | Solution/ dropsOphthalmic | 60219-1526 | 60219-1526-03 | — |
| Zolmitriptan | Zolmitriptan 2.5 mg/1 | Spray, MeteredNasal | 69238-2351 | 69238-2351-06 | — |
| Zolmitriptan | Zolmitriptan 5 mg/1 | Spray, MeteredNasal | 69238-2352 | 69238-2352-06 | — |
| Estradiolestradiol transdermal | Estradiol 1.25 mg/1.25g | GelTopical | 69238-2448 | 69238-2448-03 | — |
| Estradiolestradiol transdermal | Estradiol 1 mg/g | GelTopical | 69238-2449 | 69238-2449-03 | — |
| Estradiolestradiol transdermal | Estradiol .75 mg/.75g | GelTopical | 69238-2450 | 69238-2450-03 | — |
| Estradiolestradiol transdermal | Estradiol .5 mg/.5g | GelTopical | 69238-2451 | 69238-2451-03 | — |
| Estradiolestradiol transdermal | Estradiol .25 mg/.25g | GelTopical | 69238-2452 | 69238-2452-03 | — |
| Azelastine HClazelastine | Azelastine hydrochloride 205.5 ug/1 | Spray, MeteredNasal | 69238-2147 | 69238-2147-03 | — |
| Famotidine | Famotidine 40 mg/5mL | Powder, For suspensionOral | 60219-2090 | 60219-2090-04 | — |
| Naloxone Hydrochloridenaloxone | Naloxone hydrochloride 4 mg/.1mL | SprayNasal | 60219-2104 | 60219-2104-07 | — |
| Fosfomycin Tromethamine | Fosfomycin tromethamine 3 g/1 | Granule, For solutionOral | 60219-3955 | 60219-3955-01 | — |
| Mycophenolate Mofetil | Mycophenolate mofetil 200 mg/mL | Powder, For suspensionOral | 60219-1595 | 60219-1595-02 | — |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | 60219-1656 | 60219-1656-0160219-1656-05 | — |
| Sildenafil | Sildenafil 10 mg/mL | Powder, For suspensionOral | 60219-2651 | 60219-2651-01 | — |
| Ciprofloxacin | Ciprofloxacin hydrochloride 250 mg/1 | Tablet, Film coatedOral | 69238-2432 | 69238-2432-01 | — |
| Ciprofloxacin | Ciprofloxacin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 69238-2433 | 69238-2433-01 | — |
| Ciprofloxacin | Ciprofloxacin hydrochloride 750 mg/1 | Tablet, Film coatedOral | 69238-2434 | 69238-2434-0169238-2434-05 | — |
| Darunavir | Darunavir 600 mg/1 | Tablet, Film coatedOral | 60219-1144 | 60219-1144-06 | — |
| Darunavir | Darunavir 800 mg/1 | Tablet, Film coatedOral | 60219-1145 | 60219-1145-03 | — |
| Vigabatrin | Vigabatrin 500 mg/1 | For solutionOral | 60219-1425 | 60219-1425-05 | — |
| Erythromycin Ethylsuccinateerythromycin | Erythromycin ethylsuccinate 200 mg/5mL | SuspensionOral | 60219-1503 | 60219-1503-01 | — |
| Erythromycin Ethylsuccinateerythromycin | Erythromycin ethylsuccinate 400 mg/5mL | SuspensionOral | 60219-1504 | 60219-1504-02 | — |
| Spironolactone | Spironolactone 25 mg/5mL | SuspensionOral | 69238-2027 | 69238-2027-0269238-2027-08 | — |
| Doxepin Hydrochloride | Doxepin hydrochloride 50 mg/g | CreamTopical | 69238-1733 | 69238-1733-06 | — |
| Carvedilol Phosphate | Carvedilol phosphate 10 mg/1 | Capsule, Extended releaseOral | 69238-2577 | 69238-2577-0169238-2577-0269238-2577-03+1 more | — |
| Carvedilol Phosphate | Carvedilol phosphate 20 mg/1 | Capsule, Extended releaseOral | 69238-2578 | 69238-2578-0169238-2578-0269238-2578-03+1 more | — |
| Carvedilol Phosphate | Carvedilol phosphate 40 mg/1 | Capsule, Extended releaseOral | 69238-2579 | 69238-2579-0169238-2579-0269238-2579-03+1 more | — |
| Carvedilol Phosphate | Carvedilol phosphate 80 mg/1 | Capsule, Extended releaseOral | 69238-2580 | 69238-2580-0169238-2580-0269238-2580-03+1 more | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 250 mg/5mL | SolutionOral | 69238-2261 | 69238-2261-0369238-2261-0569238-2261-07 | — |
| Dapsonedaspone | Dapsone 75 mg/g | GelTopical | 69238-1627 | 69238-1627-0669238-1627-09 | — |
Amneal Pharmaceuticals NY LLC: common questions
- What is Amneal Pharmaceuticals NY LLC's NDC labeler code?
- 60219, 69238. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Amneal Pharmaceuticals NY LLC?
- Med-Code's HCPCS directory matches J1050 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.